Avanti Polar Lipids, Inc.
Avanti Polar Lipids, operating as Avanti Research, is a Croda-owned manufacturer of high-purity phospholipids, sphingolipids, and sterols serving pharmaceutical companies, diagnostic manufacturers, and academic researchers with catalog lipids, cGMP manufacturing, custom synthesis, and lipid-based formulation development.
- Company typePrivate
- Founded1967
- HeadquartersAlabaster, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Avanti Polar Lipids, Inc. does
Avanti Polar Lipids, Inc., legally Avanti Polar Lipids, LLC and operating commercially as Avanti Research, manufactures high-purity phospholipids, sphingolipids, sterols, PEGylated lipids, and cationic lipids for scientific research and pharmaceutical applications. Founded in 1967 and headquartered in Alabaster, Alabama, the company has built an integrated capability set spanning catalog research-use-only (RUO) lipids, custom synthesis, lipidomics and analytical services, formulations development for liposomes, lipid nanoparticles (LNPs), emulsions, and adjuvants, and cGMP contract manufacturing of pharmaceutical-grade lipids for clinical and commercial supply. Its product range covers nucleic acid delivery (mRNA, siRNA, gene therapy), vaccine adjuvant systems, protein and peptide delivery, and small molecule delivery, with named products including DSPE-PEG(2000) Maleimide, Plasma Ceramide SPLASH, DOPE (18:1 PE), and DOTAP.
The company monetizes through a hybrid model: unit-priced catalog sales of RUO lipids via a direct e-commerce platform with quick reorder and account management features, paired with account-based, contract-style engagements for cGMP manufacturing, custom synthesis, and formulations development projects. Distribution combines self-serve online ordering for the research long tail with direct enterprise sales for pharmaceutical and diagnostic customers; the company explicitly markets itself as supporting customers from concept through commercialization. Avanti is wholly owned by UK-listed specialty chemicals conglomerate Croda International Plc (LSE: CRDA), and operates as the Avanti Research brand under Croda's Health Care portfolio, leveraging parent distribution and scale-up resources while maintaining a specialized focus on lipid chemistry.
Its customer base is concentrated in pharmaceutical companies developing lipid-based drug formulations and nucleic acid therapeutics, diagnostic manufacturers requiring high-quality lipid reagents, and academic and government research institutions. The firm holds NSF ISR certification and markets cGMP-compliant supply for clinical and commercial use. Recent strategic emphasis has been on nucleic acid delivery applications, exemplified by a 2026 collaboration with NovoArc on archaeal tetraether lipid LNPs, and on operational integration with Croda via a June 2026 SAP migration affecting RUO product codes.
Avanti Polar Lipids, Inc. firmographics
Firmographics- Name
- Avanti Polar Lipids, Inc.
- Legal name
- Avanti Polar Lipids, LLC
- Website
- https://avantilipids.com
- Company type
- Private
- Founded year
- 1967
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Avanti Polar Lipids, operating as Avanti Research, is a Croda-owned manufacturer of high-purity phospholipids, sphingolipids, and sterols serving pharmaceutical companies, diagnostic manufacturers, and academic researchers with catalog lipids, cGMP manufacturing, custom synthesis, and lipid-based formulation development.
- Ownership category
- akta.pro rank
Avanti Polar Lipids, Inc. industry classification
Industry- Product category
- Specialty Lipid Manufacturing
- NAICS
- Starch and Vegetable Fats and Oils Manufacturing (31122)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Fats & Oils (2070)
- akta.pro primary industry
- Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids) (AFAJAKAC)
- akta.pro secondary industry
- Metabolomics & Lipidomics Services (HLAGANAG)
Keywords
Where Avanti Polar Lipids, Inc. is headquartered
LocationHeadquarters
- HQ city
- Alabaster
- HQ country
- United States
- HQ region
- North America
Markets served
Avanti Polar Lipids, Inc. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Research Products: Sale of high-purity lipid research products including phospholipids, fatty acids, PEGylated lipids, and specialty lipids through e-commerce platform
- cGMP Manufacturing Services: Contract manufacturing of pharmaceutical-grade lipids under cGMP conditions for clinical trials and commercial supply
- Analytical Services: Lipid analysis and testing services for quality control and research support
- Formulations Development: Custom formulation development services for lipid-based drug delivery systems
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Research Products (RUO) |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Avanti Polar Lipids, Inc. product offering
Product offeringCore offering
Avanti Polar Lipids (operating as Avanti Research) manufactures high-purity phospholipids, sphingolipids, sterols, PEGylated lipids, and cationic lipids for scientific research and pharmaceutical applications. The company sells research-grade lipid products via its e-commerce platform and provides cGMP contract manufacturing, custom synthesis, lipid-based formulation development (LNPs, liposomes, emulsions), and lipidomics analytical services for pharmaceutical, diagnostic, and research customers.
Product overview
Avanti Research offers high-purity lipids for scientific research along with cGMP manufacturing, analytical services, and lipidomics solutions. The product portfolio includes research products (lipids, phospholipids, PEGylated lipids), custom synthesis services, formulations development (adjuvant systems, nucleic acid delivery, protein delivery, small molecule delivery), cGMP manufacturing for pharmaceutical applications, and lipidomics services. The company operates as a Croda brand, providing products and services from research through commercialization, with offerings including specific lipid products like DSPE-PEG(2000) Maleimide, Plasma Ceramide SPLASH, DOPE, and laboratory equipment such as extruder sets.
Differentiator
Problem solved
Functional benefit
Products and services
- cGMP Manufacturing Contract manufacturing services for pharmaceutical-grade lipids under cGMP conditions, supporting clinical and commercial supply for pharmaceutical customers.
- Formulations Development Development services for lipid-based drug formulations including adjuvants, nucleic acid delivery systems (LNPs for mRNA/siRNA), protein/peptide delivery, and small molecule delivery.
- Lipidomics & Custom Lipidomics Mixtures Analytical lipidomics services and custom lipidomics mixtures used for lipid profiling, biomarker research, and diagnostic assay development.
- Custom Synthesis Custom synthesis services producing specialized lipids and lipid derivatives to meet unique research and pharmaceutical development requirements.
- DSPE-PEG(2000) Maleimide PEGylated lipid used in drug delivery and liposome formulation research.
- Plasma Ceramide SPLASH™ Plasma ceramide mixture used as a quantitative lipidomics standard for research and analytical applications.
- DOPE (18:1 PE) Dioleoylphosphatidylethanolamine (DOPE), a neutral phospholipid used in liposome and lipid nanoparticle formulations for drug delivery research.
- Extruder Set With Holder/Heating Block Laboratory extruder equipment used to prepare liposomes and lipid nanoparticles and to control particle size during formulation.
- Adjuvant Systems Lipid-based adjuvant systems designed for vaccine and immunotherapy applications.
- Nucleic Acid Delivery Lipid nanoparticle formulations and supporting lipids for mRNA, siRNA, and gene therapy delivery applications.
- Protein Delivery Lipid-based systems for the delivery of protein and peptide therapeutics.
- Small Molecule Delivery Lipid-based formulations for oral and injectable delivery of small molecule drugs.
Companies that use Avanti Polar Lipids, Inc.
Customer profileSegments3 records
Ideal customer profiles3 records
Avanti Polar Lipids, Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Avanti Polar Lipids, Inc. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NovoArccoreAvanti Research and NovoArc are collaborating on lipid nanoparticle and liposome design using archaeal tetraether lipids. This partnership advances next-generation delivery systems for nucleic acid therapeutics and vaccines, combining Avanti's lipid expertise with NovoArc's platform technology.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Avanti Polar Lipids, Inc. competitors and assessment
Company assessmentDirect peers
- Lipoid GmbH: German manufacturer of high-purity phospholipids and specialty lipids for pharmaceutical, cosmetic, and food applications. Most direct comparable to Avanti in phospholipid chemistry and pharma-grade lipid manufacturing, and co-listed among leading industry manufacturers.
- NOF Corporation: Japanese specialty chemical company with a major phospholipid and PEG-lipid franchise serving drug delivery and LNP formulation markets. Highly comparable to Avanti in serving nucleic acid delivery and pharmaceutical excipient customers.
- CordenPharma: Global CDMO offering lipid-based drug formulation and manufacturing services, including LNPs for mRNA therapeutics. Directly comparable to Avanti's cGMP manufacturing and formulation development service lines.
- Cayman Chemical: US-based supplier of high-purity research biochemicals including lipids, lipid mediators, and lipidomics standards. Directly comparable to Avanti's research products catalog and custom synthesis offerings.
- ABITEC Corporation: US specialty lipid manufacturer producing phospholipids, structured lipids, and functional lipid ingredients for pharmaceutical, nutritional, and industrial applications. Closely comparable to Avanti in lipid chemistry specialization.
- Echelon Biosciences: Specialty supplier of lipid research reagents, lipid nanoparticles, and custom lipid synthesis services for academic and industrial researchers. Comparable niche overlap with Avanti's research products and custom synthesis business.
Broad incumbents
- Evonik Industries: Global specialty chemicals company with significant pharmaceutical excipients and lipid system offerings (including RESOMER bioresorbable polymers and lipid-based delivery solutions). Comparable as a broader incumbent serving pharmaceutical delivery and formulation customers.
- Merck KGaA (Life Science/Sigma-Aldrich): Major life science tools and reagents supplier offering an extensive catalog of lipids, lipid conjugates, and LNP components under the Sigma-Aldrich and Supelco brands. Comparable as a broad incumbent serving research and pharmaceutical lipid demand.
- Croda International Plc (Parent): UK-listed specialty chemicals conglomerate that owns Avanti Polar Lipids and operates adjacent life sciences, pharmaceutical, and personal care ingredient franchises. Provides the strategic, distribution, and capital context for Avanti's positioning.
Emerging players
- Bio-Techne: Life sciences tools company offering lipid-based reagents, exosomes, and nucleic acid delivery reagents through its Tocris, R&D Systems, and ProteinSimple brands. Emerging competitor in lipid-enabled delivery reagents with broader portfolio reach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Avanti Polar Lipids, Inc. social profiles
Digital presenceAvanti Polar Lipids, Inc. compliance and trust
Trust signalCompliance1 record
Avanti Polar Lipids, Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Avanti Polar Lipids, Inc. leadership team
Management profileNumber of profiles
Avanti Polar Lipids, Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Avanti Polar Lipids, Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Avanti Polar Lipids, Inc.
What does Avanti Polar Lipids, Inc. do?
Avanti Polar Lipids (operating as Avanti Research) manufactures high-purity phospholipids, sphingolipids, sterols, PEGylated lipids, and cationic lipids for scientific research and pharmaceutical applications. The company sells research-grade lipid products via its e-commerce platform and provides cGMP contract manufacturing, custom synthesis, lipid-based formulation development (LNPs, liposomes, emulsions), and lipidomics analytical services for pharmaceutical, diagnostic, and research customers.
Is Avanti Polar Lipids, Inc. a public or private company?
Avanti Polar Lipids, Inc. is a private company. It is classified as corporate owned and is currently operating.
When was Avanti Polar Lipids, Inc. founded?
Avanti Polar Lipids, Inc. was founded in 1967. It employs 101 to 250 people.
Where is Avanti Polar Lipids, Inc. based?
Avanti Polar Lipids, Inc. is headquartered in Alabaster, United States, in the North America region.
How does Avanti Polar Lipids, Inc. make money?
Four revenue lines are on record. Research Products are the primary driver. The others are cGMP Manufacturing Services, analytical Services and formulations Development.
Who are Avanti Polar Lipids, Inc.'s main competitors?
Direct peers on record are Lipoid GmbH, NOF Corporation, CordenPharma, Cayman Chemical, ABITEC Corporation and Echelon Biosciences. Broad incumbents are Evonik Industries, Merck KGaA (Life Science/Sigma-Aldrich) and Croda International Plc (Parent). Bio-Techne is listed as an emerging player.
Does Avanti Polar Lipids, Inc. have an API?
No public API is recorded for Avanti Polar Lipids, Inc..
What industry is Avanti Polar Lipids, Inc. in?
Avanti Polar Lipids, Inc.'s product category is Specialty Lipid Manufacturing. Its primary akta.pro industry code is AFAJAKAC, Omega-3 & Specialty Lipids (Fish/Algal Oils, EPA/DHA, MCTs, CLA, Phospholipids), with a secondary code of HLAGANAG, Metabolomics & Lipidomics Services. Its NAICS code is 31122 and its SIC code is 2833.